National Cancer Institute U.S. National Institutes of Health | www.cancer.gov
U.S. National Institute of Health www.cancer.gov
Transplant Cancer Match Study

Home

The National Cancer Institute (NCI) is conducting the Transplant Cancer Match Study to examine cancer risk in solid organ transplant recipients. The study is a close collaboration among researchers and staff at various federal and state government agencies:

Solid organ transplantation is a life-saving procedure for individuals living with end-stage organ disease. However, people who receive an organ transplant subsequently have an elevated risk for some cancers. This high risk occurs because the medications that recipients take to prevent rejection of the transplanted organ weaken the immune system. Also, some other cancer risk factors are common among transplant recipients.

By studying the patterns of cancer risk among transplant recipients, the Transplant Cancer Match Study investigators seek to better understand how the immune system protects people from developing cancer. Another goal of the study is to increase the safety of organ transplantation, by identifying cancers where the risk is especially high and looking for opportunities to improve transplant practice.

The study does not recruit participants, because it uses only data previously collected by public health agencies.